LOW EXPRESSION OF NIBRIN PREDICTS BETTER PROGNOSIS IN PATIENTS WITH OVARIAN CANCER TREATED WITH TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD)

被引：0
|
作者：
Aracil, M. [1 ]
Nieto, A. [1 ]
Tanovic, A. [2 ]
Monk, B. J. [3 ]
Kaye, S. B. [4 ]
Poveda, A. [5 ]
Herzog, T. J. [6 ]
Parekh, T. [7 ]
Badri, N. [2 ]
Galmarini, C. M. [1 ]
机构：
[1] PharmaMar, Dept Res & Dev, Madrid, Spain
[2] PharmaMar, Med Affairs, Madrid, Spain
[3] St Josephs Hosp, Creighton Univ Sch Med, Div Gynecol Oncol, Phoenix, AZ USA
[4] Royal Marsden Hosp, Dept Canc Med, Sutton, Surrey, England
[5] Valencian Inst Oncol, Dept Gynecol Oncol, Valencia, Spain
[6] Columbia Univ Coll Phys & Surg, Div Gynecol Oncol, New York, NY 10032 USA
[7] Janssen LLC, Dept Res & Dev, Raritan, NJ USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase III study of trabectedin (T) plus pegylated liposomal doxorubicin (PLD) versus PLD for treatment of advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer.
    Coleman, Robert L.
    Monk, Bradley J.
    Knoblauch, Roland Elmar
    Parekh, Trilok V.
    Triantos, Spyros
    Maul, Raymond Scott
    Park, Youn Choi
    Herzog, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
    Rubio, Maria Jesus
    Manzano, Aranzazu
    de Sande, Luis Miguel
    Estevez-Garcia, Purificacion
    Gordon, Maria del Mar
    de Prado, Diego Soto
    de Aranguiz, Blanca Hernando Fernandez
    Guerra-Alia, Eva M.
    Carbo-Bague, Anna
    Romero, Ignacio
    Corbellas, Miguel
    Gonzalez-Haba, Alba
    Robles-Barraza, Carlos E.
    Martinez-Garcia, Jeronimo
    Gonzalez-Martin, Antonio
    BMC CANCER, 2024, 24 (01)
  • [43] Trabectedin-pegylated liposomal doxorubicin compared to cisplatin desensitization regimen-paclitaxel in ovarian cancer patients
    Paulsen, Torbjorn
    Birgisdottir, Alda
    Myklebust, Tor Age
    Dorum, Anne
    Eriksson, Ane Gerda Zahl
    Vilming, Bente
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (06) : 32 - 39
  • [44] Trabectedin as a single agent and in combination with pegylated liposomal doxorubicin - activity against ovarian cancer cells
    Marczak, Agnieszka
    Denel, Marta
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (03): : 149 - 152
  • [45] Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone
    Krasner, Carolyn N.
    Poveda, Andres
    Herzog, Thomas J.
    Vermorken, Jan B.
    Kaye, Stanley B.
    Nieto, Antonio
    Lardelli Claret, Pilar
    Park, Youn Choi
    Parekh, Trilok
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 161 - 167
  • [46] ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER
    Coleman, R.
    Bidzinski, M.
    Kutarska, E.
    Symanowski, J.
    Nguyen, B.
    Rangwala, R. A.
    Naumann, R. W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [47] EXTENDING THE PLATINUM-FREE INTERVAL (PFI) WITH TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN A PATIENT WITH PARTIALLY PLATINUM-SENSITIVE (PPS) RECURRENT OVARIAN CANCER (ROC)
    Giovannoni, S.
    Marchetti, C.
    Verkhovskaia, S.
    De Benedetto, A.
    Cortesi, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1357 - 1357
  • [48] Pegylated liposomal doxorubicin in ovarian cancer patients with renal compromise
    Basu, C. K.
    Mukhopadhyay, A.
    Pandey, R.
    Dey, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
    Tang, Lichen
    He, Min
    Wu, Jiong
    Wang, Zhonghua
    Liu, Guangyu
    Yu, Keda
    Geng, Cuizhi
    Fan, Zhimin
    Ling, Rui
    Qiao, Guangdong
    Cai, Li
    Luo, Ting
    Jin, Feng
    Wang, Haibo
    Zhang, Anqin
    Zhang, Hongwei
    Zeng, Xiaohua
    Wang, Xiaojia
    Jiang, Ming
    Shao Zhimin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Trabectedin in combination with pegylated liposomal doxorubicin: A retrospective analysis in patients with platinum-sensitive relapsed ovarian cancer.
    Nicoletto, Maria Ornella
    Baldoni, Alessandra
    Casarin, Alessandra
    Nardin, Margherita
    Baretta, Zora
    Randon, Giovanni
    Lardelli, Pilar
    Nieto, Antonio
    Alfaro, Vicente
    Rigamonti, Claudia
    Conte, Pier Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345